Glioblastoma, Adult

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Kazia Therapeutics
Kazia TherapeuticsAustralia - Sydney
1 program
1
PaxalisibPhase 2Small Molecule1 trial
Active Trials
NCT03522298CompletedEst. Mar 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Kazia TherapeuticsPaxalisib

Clinical Trials (1)

NCT03522298Kazia TherapeuticsPaxalisib

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Start: May 2018Est. completion: Mar 2023
Phase 2Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
32m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
32m ago

Office Administrator

SystImmune
32m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
43m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
46m ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
46m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)